跳至主要内容
临床试验/NCT06087588
NCT06087588已完成4 期

The Impact of the Pericapsular Nerve Group Block (PENG) Chemical Neurolysis on the Quality of Life of Patients with Advanced Hip Osteoarthritis. a Randomized, Prospective Double-blinded Clinical Trial.

Poznan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年10月17日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
NRS score

研究概览

简要总结

PENG neurolysis in advanced osteoarthritis of the hip joint.

详细描述

The study aims to assess the safety and effectiveness of regional pain treatment methods and their impact on the quality of life of patients with advanced osteoarthritis of the hip joint.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of the Pain Treatment Clinic of the Transfiguration of Jesus Clinical Hospital of the Medical University of Poznań will be qualified for the study
  • patients with coxarthrosis or gonarthrosis who failed to achieve satisfactory pain control (NRS>3) despite the use of NSAIDs, Paracetamol, and co-analgetics
  • Age of patients: from 18 to 110 years of age.
  • Caucasian patients can give informed, complete, written consent.

排除标准

  • suspected or diagnosed opioid dependence syndrome
  • active cancer

研究组 & 干预措施

sham PENG block

Active Comparator

PENG block - 20ml 0,9% normal saline

干预措施: 0.9%sodium chloride (Drug)

PENG neurolysis

Active Comparator

PENG neurolysis with 5ml 95% ethanol

干预措施: 95% ethanol (Drug)

结局指标

主要结局

NRS score

时间窗: 6 months after procedure

The NRS (Numeric Pain Rating Scale) is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.

次要结局

  • Health Questionnaire (EQ-5D-5L)(6 months after procedure)
  • neurological deficits(6 months after procedure)
  • total opioid consumption(6 months after procedure)

研究者

发起方
Poznan University of Medical Sciences
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验